Navigation Links
Women Health Market Growth Prospects for 2014 to 2018 Analyzed and Forecasts a New Research Report at

Dallas, Texas (PRWEB) July 17, 2014

In the recent past, vendors have entered into several agreements or partnerships to develop or introduce new products or drugs in the Global Women's Health market. Some of the major acquisitions include Conceptus by Bayer, Warner Chilcott by Actavis, Uteron Pharma by Watson Pharmaceuticals, and Barr Pharmaceuticals by Teva Pharmaceutical. Some of the other prominent collaborations include Bayer with EndoCeutics to develop Vaginorm for treatment of vaginal atrophy, AbbVie with Neurocrine Biosciences to develop and commercialize Elagolix, and all next-generation GnRH antagonists for women's and men's health.

According to the report, the growth of the Global Women Health market is curtailed by some serious challenges. One of the main challenges is the patent expiry of major blockbuster drugs during the forecast period. Some of the patent expiries of top leading products include Bayer’s Mirena and Yaz, Eli Lilly's Evista, and F. Hoffmann-La Roche's Boniva.

The report covers the present scenario and the growth prospects of the Global Women’s Health market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for the well being of women, which are listed below based on their application segment:

  •     Postmenopausal Osteoporosis (Drugs)
  •     Hormonal Contraceptives (Drugs and Devices)
  •     Menopause (Drugs)
  •     Infertility (Drugs)
  •     Endometriosis (Drugs)
  •     Polycystic Ovary Syndrome (Drugs)
The Global Women’s Health Market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC regions; it also covers the Global Women’s Health market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Purchase Report @

The report recognizes the following companies as the key players in the Women's Health Market: Actavis plc, Bayer AG , Eli Lilly and Co., Merck & Co., Pfizer Inc. , AbbVie Inc., Adamis Pharmaceuticals Corp., Agile Therapeutics Inc., Amgen Inc., ANI Pharmaceuticals Inc., ApothecusPharmaceutical Corp., AstraZeneca plc, Blairex Laboratories Inc., Catalysis SL, Crinetics Pharmaceuticals Inc., Dexa Medica Group, EffRx Inc., Ferring International Center SA, GlaxoSmithKline plc, HLL Lifecare Ltd., Janssen Pharmaceutical Inc., Ligand Pharmaceuticals Inc., Lipocine Inc., Lupin Pharmaceuticals Inc., Mayer Laboratories, Medicines 360,Mylan Laboratories Inc., Neurocrine Biosciences Inc., Pantarhei Bioscience BV, and Teva Pharmaceuticals Inc.

Key Market Driver

  •     Increase in Aging Female Population
Key Market Challenge
  •     Patent Expiry of Major Blockbuster Drugs
Key Market Trend
  •     Rise in Strategic Partnerships
Further, the report states that the growth of the Global Women's Health market is curtailed by some serious challenges. One of the main challenges is the patent expiry of major blockbuster drugs during the forecast period. Some of the patent expiries of top leading products include Bayer’s Mirena and Yaz, Eli Lilly's Evista, and F. Hoffmann-La Roche's Boniva.

Key Questions Answered in this Report

  •     What will the market size be in 2018 and what will the growth rate be?
  •     What are the key market trends?
  •     What is driving this market?
  •     What are the challenges to market growth?
  •     Who are the key vendors in this market space?
  •     What are the market opportunities and threats faced by the key vendors?
  •     What are the strengths and weaknesses of the key vendors?
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1.1 Postmenopausal Osteoporosis
07.1.2 Hormonal Contraceptives
07.1.3 Menopause
07.1.4 Infertility
07.1.5 Endometriosis
07.1.6 Polycystic Ovary Syndrome
08. Global Postmenopausal Osteoporosis Market
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Hormonal Contraceptives Market
09.1 Market Overview
09.2 Market Size and Forecast
10. Global Menopause Market
10.1 Market Overview
10.2 Market Size and Forecast
11. Global Infertility Market
11.1 Market Overview
11.2 Market Size and Forecast
12. Global Endometriosis Market
12.1 Market Overview
12.2 Market Size and Forecast
13. Global Polycystic Ovary Syndrome Market
13.1 Market Overview
13.2 Market Size and Forecast
14. Geographical Segmentation
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
23. Key Vendor Analysis
24. Other Reports in this Series
29 - List of Exhibits

Explore other reports on Pharmaceutical Market, Therapeutics Market.

About Us: ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities, and forecasts about industries that help businesses make the right decision.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Screening costs increased in older women without changing detection rates of ESBC
2. Women’s Excellence Now Offers Bladder Instillation Therapy for Interstitial Cystitis at All Locations in Oakland County, Michigan
3. Foods that Fight Inflammation, from the July 2014 Harvard Women's Health Watch
4. National Association of Professional Women Announces Pamela Erlandson, Owner, Erlandson Surgical & Medical Legal Consulting Svcs, as a 2014 Professional Woman of the Year
5. National Association of Professional Women Announces Elizabeth (Betsy) L.M. Miller, Founder, Child Care Health & Safety, LLC, as a 2014 Professional Woman of the Year
6. National Association of Professional Women Announces Dr. Karen Riedel, Director of Speech Language Pathology, NYU Medical Center, as a 2014 Professional Woman of the Year
7. Study: Young women with sexy social media photos seen as less competent
8. Women Changing Lives Through Food
9. Expressive therapy" intervention assists women living with HIV
10. Womens Medicine Collaborative examines safety of fecal transplant to treat C. difficile
11. Growing old with HIV: Age-related diseases are bigger problem for African American women
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... toilets were," said an inventor from Hillside, N.J. "Many people catch diseases simply ... so that individuals will always be protected from germs." , He developed the ...
(Date:11/27/2015)... ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating ... of 30 (see Table 1-1 ). More than 3.7 billion people under the ... virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
(Date:11/27/2015)... ... 2015 , ... Dr. Thomas Dunlap and Dr. Patrick Coleman ... with Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , ... in similar ways and require time-critical intervention to avoid large area heart damage and ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they ... to buy during the Black Friday and Cyber Monday massage chair sales ... the Internet high and low to find the best massage chair deals, they can ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
Breaking Medicine Technology: